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1. Introduction 
A large number of firms continue to face 
financial constraints which have been 
intensified by the 2008 financial crisis. The 
interplay of EU specific economic 
characteristics makes the funding shortfall 
for innovative projects particularly acute in 
Europe. In particular, EU high-tech start-ups 
and young innovative SMEs are seriously 
financially constrained; this has been 
identified as a major barrier to their growth, 
to which policymakers strive to find suitable 
solutions (European Commission, 2013).  
In a context where investments in 
innovation are at the core of firms’ 
competitiveness strategies and on the top 
of countries’ and regions' "growth and jobs" 
policy agendas, a better understanding of 
the current and emerging drivers and 
barriers for innovation financing is crucial. 
This policy brief relies on the results of a 
recent European Conference1 on the subject. 
It presents  recent empirical evidence and 
attempts to draw a number of policy-
relevant messages to be brought to the 
attention of policymakers. 
                                                        
1 The Fourth European Conference on Corporate R&D and 
Innovation (CONCORDi-2013) – Seville, Spain, 26-27 
September 2013 – focused on 'Financing R&D and 
innovation for firms' growth', organised by the European 
Commission's Joint Research Centre 
http://iri.jrc.ec.europa.eu/concord/2013/index.html  
2. Background 
The financing of R&D and innovation 
activities is susceptible to market failures. 
Extensive evidence has shown that these 
failures are mainly related to the innate 
uncertainty of innovative projects, the 
difficulties innovators face in appropriating 
their benefits and the asymmetric 
information and moral hazard that pervade 
relationships between lenders, equity 
investors and borrowers (Hall and Lerner, 
2010). 
Research on financial sources and 
constraints to firms’ growth strategies has 
grown enormously in recent decades, 
producing an extensive number of results, 
whose research and policy implications 
merit further scrutiny. For example, evidence 
on the consequences a firm’s capital 
structure has on its capacity to finance R&D 
and innovation (and vice versa) has shed 
new light on the relative merits of bank-
based versus market-based financial 
systems as sources of finance (Dosi, 1990; 
Brown et al., 2009). However, whether this 
generates country specificities within Europe 
in the finance-innovation-growth link that 
could be exploited by policymakers for the 
sake of innovation deserves further 
investigation (Revest and Sapio, 2012).  
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The related issue of the gap between the 
external and internal costs of R&D 
investments is also in need of further 
analysis. The ways in which companies 
could mitigate the opacity of their 
innovative projects in investors’ eyes and 
their lack of collateralisable assets, the 
remedies against the morally hazardous 
behaviours (e.g. self-dealing) of their 
managers with respect to internal cash 
flows and their understandable reluctance 
to invest external capital in risky projects, 
are only some of the issues of the 
phenomenon at stake (Hall & Lerner, 2010).  
Furthermore, the available evidence 
confirms that firms' specificities, such as 
location, sector of activity, size and age, 
need to be considered when analysing the 
magnitude and implications of the 
"financing gap". In this respect, younger and 
smaller firms have more difficulties in 
gaining access to finance and in obtaining 
long-term loans and they are commonly 
characterised by lower levels of equity 
capital (Cooley and Quadrini, 2001). These 
generally more severe financial constraints 
affect their innovation investments and, as 
recent research shows, their growth 
performance and persistence (Ciriaci et al., 
2012). 
The evidence of the failures that affect the 
financing of R&D and innovation has 
stimulated a lot of work on the need for 
public policy to overcome these failures at 
different levels – national, supra- and sub-
national – and on the policy measures 
needed to actually achieve it. At the same 
time, research on the role of financing 
facilitators, like venture and seed capital, 
business angels, and crowdsourcing (to 
mention a few) has grown. 
Important results have been achieved also 
in this field (O’Sullivan, 2006; Hall and 
Lerner, 2010), shedding light on the 
important European specificities with 
respect to the US. This is for example the 
case of the quantitative and qualitative 
deficits of its venture capital industry: as 
Figure 1 shows, European countries lag 
behind the USA in terms of venture capital 
investments. In addition to that, the failures 
of their high-tech stock markets and the 
shortage of high-risk loans (Revest and 
Sapio, 2012) are the most significant. Some 
of these specificities have been aggravated 
as a result of the financial crisis.  
As Figure 2 shows, access to loans for 
companies located in some Member States 
has severely worsened during 2011-12 as 
compared with the 2007-08 period.  
This new context calls for further scrutiny of 
the policy options available to improve this 
situation. On the one hand, direct policy 
measures – such as the use of R&D tax 
credits - need careful policy assessment in 
order to asses their “additionality” and 
exclude the risk of crowding-out effects 
(Santarelli and Vivarelli, 2002; Ientile and 
Mairesse, 2009). On the other hand, indirect 
policy measures – such as institutional 
support to private venture capital, or to a 
public form of venture capital (Bonaccorsi 
and Montaina, 2012) - should control for 
their actual role in enabling the 
development of already innovative 
companies (“coach function”), rather than in 
picking-up companies that only have the 
potential to become so (“scout function”) 
(Bottazzi and Da Rin, 2003). 
 
 
 
 
 
 
Figure 1. Venture capital investment, 2012
As a percentage of GDP (Source: OECD, 2013) 
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3. New evidence from CONCORDi-
2013  
The CONCORDi-2013 Conference was 
structured around two topics which aimed to 
represent two sides of the same coin, 
namely the issue of R&D and innovation 
financing for corporate growth. Topic 1 took 
a company-level perspective and focused on 
the financial sources available, the 
constraints that firms perceive in accessing 
them, and the strategic choices they need to 
take to transform them into superior 
innovation and growth. Topic 2 took a policy 
perspective, addressing the effectiveness of 
the financing facilitators which firms use 
(e.g. venture capital, business angels and 
crowdsourcing), the policy needs that they 
pose, and the kind of actions and 
measurements needed to address them. In 
the following two sections, the main 
evidence presented for each topic is 
summarised and main policy-relevant 
messages highlighted. 
 
3.1 Financial sources, constraints and 
firms' growth strategies 
Assessing the importance of various 
external factors affecting firms’ R&D efforts 
and innovative activities is crucial to 
understand the issue at stake. The studies 
presented during CONCORDi-2013 reinforce 
previous evidence on the negative impact of 
financial constraints on innovative activities; 
furthermore, they highlight the importance 
of non-financial hurdles. There is a high 
degree of heterogeneity among firms. In 
particular, financial constraints are most 
common for those with higher innovative  
 
 
potential, and whose environment is 
characterised by high uncertainty and 
limited information disclosure.  
Evidence presented during the conference 
shows that by adopting certain behaviours, 
firms can either reduce or magnify their 
financial constraints. How firms’ own 
behaviours affect market perceptions and 
the severity of financial constraints is thus a 
relevant dimension to be analysed to 
properly understand the finance-innovation 
mechanism. In this respect new important 
evidence emerged from the conference. 
Strong intellectual property activities (patent 
applications and scientific publications) are 
associated with greater R&D activities in 
high-technology sectors, and attenuate the 
financial constraints. This occurs especially 
for small firms, for which information 
asymmetries may be particularly high and 
collateral value is low.  
Policy-relevant message 1: The quality 
and quantity of financial disclosure 
rules/practices positively affect firms' 
investment in R&D as well as the speed of 
firms' growth, especially in high-tech 
industries. Besides, it appears that the tax 
treatment of R&D has a relatively stronger 
effect on R&D in less innovative industries. 
Moreover, it was shown that the relation 
between firms’ financial constraints and 
their innovative activities is not linear and 
unidirectional. New, robust evidence of two-
way feedback effects (bi-directional) was 
provided. More precisely, these papers show 
that what makes firms more financially 
constrained is in fact their R&D and 
innovation activities, while the start of such 
Figure 2. Ease of access to loans, 2007-08 and 2011-12 
Scale from 1 to 7 from hardest to easiest, weighted averages (Source: OECD, 2013)   
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activities appeared to be initially less 
financially constrained.  
 
Policy relevant message 2: The financing 
challenges of innovation do not stop when a 
firm introduces a new product or service, but 
continue – and may in fact intensify – in the 
early stages of diffusion. 
Finally, findings from the existing literature 
on the interaction between firms’ financial 
constraints, innovative investments and 
exports have been confirmed. In addition, it 
has been proved that this interaction is 
dependent on the availability (or lack) of 
financial resources. Moreover, it seems that 
financial constraints can shape the relation 
between innovative activities and exports in 
a very particular way: if financial constraints 
bind, export and innovative activities are 
less likely to be complementary to each 
other. 
Policy relevant message 3: Financial 
constraints (or the level of financial health 
of the firm) intertwine with product 
competition in preventing firms from 
investing in R&D to gain foreign market 
shares and to grow. 
3.2. Public policies, policy means and 
financing facilitators 
A first set of policies which merit 
investigation are those concerning R&D tax 
credits. Evidence from the recent works 
presented during the CONCORDi-2013 show 
that R&D tax incentive schemes targeting 
large companies could generate positive 
effects. In the case of the UK, in particular, 
an increase of 18% in business R&D has 
been estimated with respect to the 
counterfactual scenario of no tax credit; 
thus implying a user cost elasticity of 1.35. 
Furthermore, it is better to have two policy 
instruments rather than just one: the 
combination of R&D tax credits and R&D 
subsidies is effective in preventing crowding 
out effects, as evidence shows from the 
Belgian experience. In fact, evidence shows 
that the effects of R&D tax credits and R&D 
subsidies are differentiated according to the 
characteristics of the firm and of R&D 
projects. In the case of the new French R&D 
tax credit scheme, which is particularly 
generous in terms of the resources 
dedicated to it (it has absorbed 0.25% of its 
GDP), important specificities arise. It was 
estimated that this programme has led to a 
13% increase of business R&D, but without 
a visible increase in innovation output as 
measured by patent applications. This result 
emphasises the need to include appropriate 
output indicators among the ex-ante 
objectives and subsequent evaluation 
criteria of such policy schemes, in order to 
ensure that private returns to R&D (e.g. in 
terms of patent applications) are achieved. 
Policy relevant message 4: The latest 
empirical evidence point to positive impacts 
of tax credit schemes in the levels of 
business R&D spending. Such schemes 
should be tailored to firms’ specificities and 
combined with other instruments to avoid 
crowding-out effects. Besides the increase 
of R&D, schemes should also target and be 
evaluated in terms of innovative outputs. 
A closer look at the issue of effectiveness of 
R&D subsidies provides additional 
interesting insights. Looking at the Flemish 
scheme, which treats funds supporting the 
Research (R) phase differently from those 
devoted to the Development (D), shows that 
targeting "R" induces more private 
investment than targeting "D". In addition, 
there are significant “cross-effects” with 
more significant spill-overs stemming from 
the "R" support to the "D" private 
performances; these effects depend highly 
on the size of the firms targeted. In the 
Finnish experience subsidies are allocated - 
through the selection of the Finnish agency 
TEKES - to more technologically challenging, 
riskier and more novel innovation projects. 
However, important differences arise 
depending on firm size: commercial risk is 
negatively correlated to subsidy decisions 
for SMEs, but positively correlated for large 
firms. Finally, the experience of the Spanish 
CDTI agency shows that young firms, 
exporters, large firms, firms operating in 
high/medium-tech industries, and especially 
firms with previous experience in similar 
programmes, are more likely to use R&D 
subsidies. 
Policy relevant message 5: The size of 
firms and some specific characteristics 
(such as the level of internationalisation and 
innovation intensity) are important 
determinants of the positive impact of R&D 
subsidies. Large firms and high-tech sectors 
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seem to benefit more, particularly when 
subsidies target earlier phases of knowledge 
creation (R vs. D) and more risky projects.  
Finally, new indications on what are the best 
(and new) financial support policies 
favouring the growth of new innovative 
firms have been presented. As European 
new R&D-intensive firms seldom become 
very big, public policies try to address this 
issue in different ways. However, new 
evidence from Germany shows the difficulty 
of such a task. Results from the analysis 
presented at the Conference show that R&D 
subsidies targeting young firms are not 
effective, unless such firms operate in high-
tech sectors. On the other hand, empirical 
evidence indicates that public venture 
capital may not be a policy solution in 
Europe. Private VC appears to be more 
conducive to firm growth than public VC 
funding. The "crowdfunding" scheme2 - a 
potentially new important way to finance 
new technology-based ventures – has 
several interesting characteristics: the 
existence of a large number of co-founders 
already indicates the cases in which there 
will be eager consumers. It seems that 
crowdfunding is evolving along the same 
lines as venture capital and could represent 
an interesting option for the public sector to 
select, with the help of citizens, the 
innovative projects to be funded. 
Policy relevant message 6: Existing public 
instruments seem not well suited to 
supporting the growth of new innovative 
companies, except in high-tech sectors. 
Private venture capital appears in this 
respect more effective than public VC. 
 
4. Policy relevant conclusions 
from CONCORDi-2013  
The main results deriving from CONCORDi-
2013 merit some research and policy 
considerations. 
(I) Financial constraints are important 
obstacles to R&D and innovation in 
European firms, and the importance of 
these obstacles depend on factors that are 
both internal and external to the firms. The 
lack of firms’ internal liquidity together with 
                                                        
2 This is the collective effort of individuals who network and pool 
their money, usually via the Internet, to support efforts initiated by 
other people or organisations. 
the lack of collateral assets (typical of 
SMEs) dampens corporate R&D and 
innovation activities. At the same time, 
strong competition and the lack of demand 
are almost as important obstacles as are 
financing constraints. This sheds new light in 
the way financial constraints need to be 
addressed: not just as merely innovation 
barriers, but also as a problem related to 
market selection mechanisms (demand for 
innovation).  
(II) The reduction of information 
asymmetries can considerably lower the 
barriers to access financial resources for 
corporate R&D and innovation activities: 
high level practices of financial disclosure, 
patenting and publications are positive 
information signals to investors and prove 
to positively affect firms' investment in 
R&D/innovation as well as the speed of 
firms' growth. Public policies can favour 
good practices of financial disclosure. 
(III) Moreover, the difficulty of accessing 
finance and its limited availability may 
apply to external financial sources, 
especially to bank loans, as banks generally 
do not possess the scope, financial products 
and competencies to deal with investment 
in high-tech projects (especially by young 
firms). Hence, venture capital could be 
considered (still) a suitable external 
financing mechanism as it reduces the time 
needed to reach the market and 
commercialise new ideas, especially for 
high-tech start-ups operating in capital-
intensive industries. Nonetheless, there are 
concerns that private venture capital is 
ultimately the proper instrument for 
financing R&D and innovation projects 
(often with medium/long-term perspectives), 
especially because the former has a short-
term horizon to harvest returns (the VC exit 
time is usually around the third year) and 
the latter the opposite. This in turn may 
produce a detrimental effect on the ability 
of VC-backed companies to produce real 
value for the economy, i.e. new products and 
jobs. New emerging instruments, as 
crowdfunding, should be considered (and 
further investigated), possibly in 
combination with other financial sources.  
(IV) In general, policy remedies to financial 
shortages and barriers do not show 
crowding-out effects, but their additionality 
is very sensitive and not yet systematic. This 
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implies that accurate design and 
coordination among different policy actions 
is needed to fully exploit their 
complementarities and synergies, and 
maximise their effectiveness. One policy 
method that fits all the cases would be an 
ideal approach but it does not seem to be 
available. In fact, tax incentives, subsidies 
and grants have different impacts 
depending on firms' size, industries, project 
specificities (riskiness, newness), growth 
phases, and on whether product or service 
characteristics are taken into account. 
Moreover, mechanisms to use public venture 
capital in combination with other 
instruments should be further investigated 
and analysed. 
(V) Finally, the great heterogeneity of 
companies and framework conditions across 
countries and regions calls for much more 
systematic and comprehensive empirical 
evidence based on proper indicators. For this 
reason better policy analyses and constant 
monitoring of the instruments used should 
be envisaged. Accordingly, both scientists 
and policymakers participating in 
CONCORDi-2013 called for establishing a 
stronger network of R&D and innovation 
policy evaluators to support the proper 
implementation of the upcoming European 
financial support instruments agreed for the 
period 2014-2020. 
 
5. Open questions for policy and 
further research needs 
Drawing on the results of CONCORDi-2013, 
a number of open questions on EU policy 
issues are still open and deserve some 
further research and policy debate, e.g.: 
 (i) EU framework conditions favouring 
the financing of risky corporate R&D and 
innovation activities 
 What are the most prominent 
framework conditions to address?  
 Is EU policy addressing them with 
adequate instruments and speed?  
(ii) EU funding sources supporting 
Research & Innovation (R&I) in enterprises 
 Is there room for possible synergies 
between EU funding sources (e.g. those 
to support R&I investments in SMEs)?  
 Is there a recipe for the best mix of 
general-purpose policy with targeted 
policy measures to address market 
imperfections in financing firms' R&I?  
(iii) EU policy-making support, policy 
evaluation and experimentation 
 What specific science-based analysis is 
most urgent to support EU 
policymakers? 
 Should future policy measures to ease 
access to investment in R&I be tested 
before their launch (e.g. the ICT 
Vouchers Scheme pilot initiative)? 
Should these measures be 
systematically monitored and 
evaluated to ensure efficiency and 
effectiveness?   
In order to help answering these questions, 
future research agendas should address, 
among others, the following topics:   
a) The magnitude, and thus relative 
importance, of the various external barriers 
to innovative activities; these include factors 
that determine why and when innovative 
firms are willing (or forced) to take action to 
alleviate their financial constraints  
b) The relation between firm growth and 
financial constraints (mechanisms; 
quantitative importance; heterogeneity).  
c) The costs and benefits, related to both 
firms and governments, of putting in place 
different mechanisms for attenuating 
financial constraints in research and 
innovation activities. 
Finally, there is a general demand for more 
and better data to implement relevant 
analyses, which would allow, among the 
others, to disentangle sector specificities 
and to extend the analyses to more 
countries or clusters of homogenous 
regions.
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that are both internal and external to firms. b) The reduction of information asymmetries can considerably lower the barriers to access 
financial resources for corporate R&D and innovation activities. c) Among external financial instruments, bank loans are the least 
attractive, while venture capital is (still) considered suitable for financing R&D and innovation projects, although they have a too short a 
time horizon to yield returns. Crowdfunding has been identified as a new emerging financial instrument. d) Policy remedies to financial 
shortages and barriers are not affected by crowding-out, but their additionality is very sensitive and not yet systematic. Public venture 
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